Vascular remodeling and endothelial dysfunction in polycystic ovary syndrome: mechanisms, clinical markers, and therapeutic implications – a narrative review
Progress in Health Sciences · 15.07.2026 · 16 (1) · 59-70
DOI: 10.5604/01.3001.0055.8499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Health Sciences, erschienen am 15.07.2026. Verfasst von Miłosz Strugała und 4 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Introduction
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is increasingly associated with an elevated risk of cardiometabolic complications. PCOS is linked to vascular changes, including endothelial dysfunction and subclinical atherosclerosis. These alterations may occur even in young women and before the development of overt cardio-vascular disease. Therefore, a comprehensive review of current evidence is needed to better understand the mechanisms of vascular remodeling in PCOS, identify clinically relevant vascular markers, and summarize potential therapeutic approaches aimed at reducing cardiovascular risk in this population.
Purpose
To review current evidence on the pathophysiological mechanisms underlying vascular remodeling and endothelial dysfunction in women with PCOS, with particular emphasis on the role of hyperandrogenism. Additionally, the study aimed to summarize clinically relevant non-invasive vascular markers and evaluate available therapeutic approaches that may reduce cardiovascular risk in this population.
Material and methods: This narrative review was based on a structured literature search conducted in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar. The search covered publications available from database inception to 31 March 2026 and focused on vascular remodeling, endothelial dysfunction, clinical vascular markers, and therapeutic approaches in PCOS. Eligible publications included original studies, reviews, meta-analyses, guidelines, and relevant mechanistic or preclinical studies.
Conclusions
Hyperandrogenism-driven vascular remodeling significantly increases cardiovascular risk in specific PCOS phenotypes. Non-invasive vascular assessment and targeted therapies may support the clinical management of cardiovascular risk in these patients. Further research should focus on large-scale prospective studies, evaluate phenotype-specific cardiovascular trajectories, and validate emerging therapeutic targets to improve long-term outcomes.
Zitieren
APA
Strugała, M., Smółka, L., Pomianowski, B., Blady, K., & Kursa, K. (2026). Vascular remodeling and endothelial dysfunction in polycystic ovary syndrome: mechanisms, clinical markers, and therapeutic implications – a narrative review. Progress in Health Sciences, 16(1), 59-70. https://doi.org/10.5604/01.3001.0055.8499
Vancouver
Strugała M, Smółka L, Pomianowski B, Blady K, Kursa K. Vascular remodeling and endothelial dysfunction in polycystic ovary syndrome: mechanisms, clinical markers, and therapeutic implications – a narrative review. Progress in Health Sciences. 2026;16(1):59-70. doi:10.5604/01.3001.0055.8499
BibTeX
@article{Strugaa2026,
author = {Strugała, Miłosz and Smółka, Leon and Pomianowski, Bartosz and Blady, Karolina and Kursa, Karolina},
title = {Vascular remodeling and endothelial dysfunction in polycystic ovary syndrome: mechanisms, clinical markers, and therapeutic implications – a narrative review},
journal = {Progress in Health Sciences},
year = {2026},
volume = {16},
number = {1},
pages = {59--70},
doi = {10.5604/01.3001.0055.8499}
}
EUVIMED